P120 catenin (p120), a Src substrate that can indirectly activate Rac1 and Cdc42, acts as an obligate intermediate between ErbB2 and Rac1/Cdc42 to modulate the metastatic potential of breast cancer cells [101,102]. Here, ERBB2 is linked to breast cancer.